Nautilus Bio (NAUT) Sof foyda bo'yicha sotuv rentabelligi

NAUT (nautilus.bio) - kompaniyaning tovar belgisi

Nautilus Biotechnology (NAUT) zamonaviy farmatsevtika vositalarini sintez qilish uchun ilg'or proteom tadqiqot tizimini ishlab chiqmoqda. GURU.Markets portali tomonidan ko'rsatilgan tarixiy savdo marjasi darajasi ushbu strategiyani tasdiqlaydi, bunda joriy daraja -13816.80 atrofida shakllangan. Biznes samaradorligi arzon DNA skriningi uchun maxsus chiplar va laboratoriyalardagi modernizatsiya qilingan optik tizimlarga asoslangan.

nautilus.bio (NAUT) - Sof marja 04.07.2022dan 19.11.2026gacha

Nautilus Bio (NAUT) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Kompaniyaning jamlanma tahlili:Nautilus Biotechnology
nautilus.bio yetakchi tovari

Sotuv marjasi daromadning har bir dollari ichidagi sof foyda ulushini belgilab, daromadni yakuniy kapitalga aylantirish samaradorligini o'lchaydi. -13816.80 ning joriy qiymati Nautilus Biotechnology (NAUT) kompaniyasining DNK sekvensirlash sohasidagi texnologik gigantlar bilan bo'lgan shiddatli raqobat sharoitida foydani saqlab qolish qobiliyatini aks ettiradi. Kompaniyaga tegishli sotuv marjasi tarixini tahlil qilish orqali investor laboratoriyalarda proteomika vositalarini joriy etishning haqiqiy xarajatlarini aniqlashi mumkin. Ushbu ko'rsatkichning qisqarishi raqobatbardoshlik ustunligining yo'qolganidan dalolat beradi, ko'rsatkichning barqarorligi esa biznes modelining chidamliligini tasdiqlaydi.

Raqobatdosh kompaniyalar tahlili

TEM: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Repligen Inc. - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi RNA|CRSP - Sof marja|GeneDx - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi RARE|Beam Tx - Sotuvning sof marjinal rentabelligi|SRPT - Sotuvning sof marjinal rentabelligi|TWST (Twist Bio) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi TXG|Sof foyda bo'yicha sotuv rentabelligi NTLA|Stoke Therapeutics Inc (STOK) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi BLFS|Sof marja WVE (Wave Life Sciences Corp)|Sof marja Maze Therapeutics MAZE|Sof foyda normasi SION|PRME - Sof marja|Kompaniya sotuv marjasi Taysha TSHA|QURE: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi MeiraGTx PLC|RGNX (REGENXBIO Inc) - Sotuvning sof marjinal rentabelligi|solidbio.com (SLDB) - Kompaniya sotuv marjasi|Sof marja Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Sotuvning sof rentabelligi|Benitec Biopharma - Sof foyda bo'yicha sotuv rentabelligi|DSGN: Sotuvning sof rentabelligi|RCKT: Sof foyda bo'yicha sotuv rentabelligi|FDMT - Sotuvning sof marjinal rentabelligi|LXEO: Sotuvning sof marjinal rentabelligi|Korro Bio Inc. - Sof foyda normasi|EDIT (editasmedicine.com) - Sotuvning sof marjinal rentabelligi|Sof marja SLN|Sof marja ProQR Therapeutics NV (PRQR)|Codexis - Sotuvning sof rentabelligi|Sof marja Sangamo SGMO|Kompaniya sotuv marjasi Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Sotuvning sof marjinal rentabelligi|GBIO - Sotuvning sof marjinal rentabelligi|BOLD: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi XCUR|Sof marja Imunon|Phio Pharmaceuticals - Sof foyda marjasi|Sof marja Mustang Bio, Inc. (MBIO)|Kompaniya sotuv marjasi TransCode Therapeutics, Inc.|Sof marja Bionano Genomics BNGO|Sof foyda normasi APDN|BLUE - Sof marja|Sof foyda marjasi IPA|Omega Therapeutics, Inc. (OMGA) - Sof marja|Singular Genomics Corp (OMIC) - Sotuvning sof marjinal rentabelligi|RGLS (Regulus Therapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|SYRS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi TBIO (Telesis Bio Inc.)|Sotuvning sof marjinal rentabelligi TRACON Pharmaceuticals Inc. (TCON)|Sof marja Unity Bio UBX